These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7459752)

  • 1. The use of propranolol in treating tardive dyskinesia.
    Roberts PW
    Can Med Assoc J; 1980 Dec; 123(11):1106-7. PubMed ID: 7459752
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of propranolol in treating tardive dyskinesia.
    Einarson TR
    Can Med Assoc J; 1981 May; 124(10):1260, 1262. PubMed ID: 7237311
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol in the treatment of tardive dyskinesia.
    Perényi A; Farkas A
    Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement in tardive dyskinesia and MMPI scores with propranolol.
    Novac A
    J Clin Psychiatry; 1986 Apr; 47(4):218-9. PubMed ID: 3957889
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of tardive dyskinesia with propranolol.
    Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S
    J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol-induced tardive dyskinesia in a patient with akathisia.
    Sandyk R
    Ann Neurol; 1985 Sep; 18(3):370. PubMed ID: 4051467
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of tardive dyskinesia with propranolol.
    Pitts FN
    J Clin Psychiatry; 1982 Aug; 43(8):304. PubMed ID: 7096269
    [No Abstract]   [Full Text] [Related]  

  • 8. Propranolol, anxiety, and tardive dyskinesia.
    Bacher NA; Lewis HA
    J Clin Psychiatry; 1983 May; 44(5):196. PubMed ID: 6133849
    [No Abstract]   [Full Text] [Related]  

  • 9. Propranolol therapy in a patient with panic disorder, tardive dyskinesia, and essential tremor.
    Olivera AA; Kiefer MW
    J Clin Psychiatry; 1984 Nov; 45(11):484-5. PubMed ID: 6490597
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose propranolol in tardive dyskinesia.
    Bacher NM; Lewis HA
    Am J Psychiatry; 1980 Apr; 137(4):495-7. PubMed ID: 6102439
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of elderly women with thyrotoxicosis to treatment for tardive dyskinesia.
    Shamrakov O; Berner Y
    Isr Med Assoc J; 1999 Nov; 1(3):201-2. PubMed ID: 10731339
    [No Abstract]   [Full Text] [Related]  

  • 12. Propranolol, chlorpromazine, and tardive dyskinesia.
    Risch SC; Cohen RM; Kalin NH
    Am J Psychiatry; 1980 Sep; 137(9):1125. PubMed ID: 7425175
    [No Abstract]   [Full Text] [Related]  

  • 13. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
    Bouckaert F; Herman G; Peuskens J
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiapride in tardive dyskinesia.
    Murphy DJ; Hughes G; Shaw GK
    Psychopharmacol Bull; 1982 Oct; 18(4):13-6. PubMed ID: 7156275
    [No Abstract]   [Full Text] [Related]  

  • 17. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS; Paige SR; Newton JE
    Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
    Bona JR
    J Clin Psychopharmacol; 2006 Apr; 26(2):215-6. PubMed ID: 16633158
    [No Abstract]   [Full Text] [Related]  

  • 20. Lecithin administration in tardive dyskinesia: clinical and biomedical correlates.
    Jackson IV; Davis LG; Cohen RK; Nuttall EA
    Biol Psychiatry; 1981 Jan; 16(1):85-90. PubMed ID: 7225479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.